BIOMAT Database Logo BIOMAT Database Logo

Pure alcoholic fatty liver and progression to cirrhosis or fibrosis. 1995

A M Ho, and L H Contardi

UI MeSH Term Description Entries
D008104 Liver Cirrhosis, Alcoholic FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING. Alcoholic Cirrhosis,Hepatic Cirrhosis, Alcoholic,Alcoholic Hepatic Cirrhosis,Alcoholic Liver Cirrhosis
D008297 Male Males
D005235 Fatty Liver, Alcoholic Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated. Alcoholic Fatty Liver,Alcoholic Steatohepatitis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

A M Ho, and L H Contardi
Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.
October 1995, Lancet (London, England),
A M Ho, and L H Contardi
Machine learning to predict progression of non-alcoholic fatty liver to non-alcoholic steatohepatitis or fibrosis.
March 2022, JGH open : an open access journal of gastroenterology and hepatology,
A M Ho, and L H Contardi
Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis.
April 2001, Liver,
A M Ho, and L H Contardi
[The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease].
June 2017, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi,
A M Ho, and L H Contardi
Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
August 2004, Alcohol (Fayetteville, N.Y.),
A M Ho, and L H Contardi
Antibodies to Escherichia coli in alcoholic and non-alcoholic patients with cirrhosis of the liver or fatty liver.
January 1973, Scandinavian journal of gastroenterology,
A M Ho, and L H Contardi
Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
June 2000, Liver,
A M Ho, and L H Contardi
Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
January 2001, The Cochrane database of systematic reviews,
A M Ho, and L H Contardi
Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
April 2005, The Cochrane database of systematic reviews,
A M Ho, and L H Contardi
[Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
November 1983, Zeitschrift fur Gastroenterologie,
Copied contents to your clipboard!